Aug 9, 2023 | Infection Control, News
CREDIT: UAB Photo Lawrence A. Tabak, D.D.S., Ph.D., acting director for the National Institutes of Health (NIH), has named Jeanne M. Marrazzo, M.D., as director of NIH’s National Institute of Allergy and Infectious Diseases (NIAID). Dr. Marrazzo is currently the... 
Aug 9, 2023 | Infection Control, News, Uncategorized
CREDIT: NIH/NIAID cc Whole-genome sequencing of shiga toxin-producing Escherichia coli (STEC) from human fecal samples found that nearly 15% harbored antimicrobial resistance (AMR) genes, English researchers reported today in the Journal of Antimicrobial Therapy. For... 
Aug 9, 2023 | Infection Control, News
CREDIT: NIH/NIAID cc Testing by a team of researchers with the Louis Stokes Cleveland VA Medical Center indicates that sporicidal disinfectants are more effective against the multidrug-resistant fungal pathogen Candida auris than quaternary-ammonium disinfectants,... 
Aug 9, 2023 | Covid-19, News
CREDIT: NIH/NIAID cc A fourth dose of the bivalent (two-strain) COVID-19 vaccine is substantially more effective against medical treatment and hospitalization than a fourth monovalent (single-strain) dose among both previously infected and never-infected people who... 
Aug 2, 2023 | Covid-19, News
By Maria Fernanda Ziegler | Agência FAPESP – Researchers at the University of São Paulo (USP) in Brazil have identified a new class of molecules capable of stopping the excessive inflammation typical of the severe form of COVID-19 without impairing the immune... 
Aug 2, 2023 | Infection Control, News
Researchers at the RIKEN Center for Sustainable Research Science (CSRS) and the University of Toronto have discovered a new way to attack fungal infections. The key is to block fungi from being able to make fatty acids, the major component of fats. Resistance to...
